The medical technology company Polarcool announces that three national teams that have qualified for the 2026 FIFA World Cup in North America will have access to the company’s concussion treatment Polarcap during the tournament. The system will be included in the teams’ medical routines for players who suffer a concussion.According to Polarcool, the decision has significant strategic value by strengthening the company’s position in acute concussion treatment, even though the direct financial impact is limited.